ArticleRespirology case reports2025
Successful Immunochemotherapy for Advanced Lung Adenocarcinoma Obstructing the Left Brachiocephalic Vein Complicated by Chylothorax.
Article in Respirology case reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
A 67-year-old male patient presented with enlarged mediastinal lymph nodes, which compressed and obstructed the left brachiocephalic vein. He also developed a chylothorax in the left pleural cavity. A biopsy of the mediastinal lymph nodes confirmed the diagnosis of lung adenocarcinoma with high programmed death-ligand 1 expression. Due to the presence of metastasis in both bilateral supraclavicular lymph nodes, curative radiation therapy was not feasible. Consequently, carboplatin, nab-paclitaxel, and atezolizumab were administered, and palliative radiation was added sequentially for the mediastinal lymph nodes. A reduction in mediastinal lymph nodes and pleural effusions was observed within 2 weeks. Subsequently, the patient achieved complete remission, including lesions outside the radiated area, and had no recurrence of pleural effusion 24 months after the initial immunochemotherapy, indicating the durable efficacy of an immune checkpoint inhibitor.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.